Media coverage about Bioamber (NYSE:BIOA) has trended somewhat positive recently, Accern reports. The research group rates the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Bioamber earned a news sentiment score of 0.11 on Accern’s scale. Accern also assigned media stories about the biotechnology company an impact score of 47.0532142961977 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

These are some of the media stories that may have effected Accern’s scoring:

Bioamber (BIOA) traded down $0.01 during midday trading on Friday, reaching $0.40. The company had a trading volume of 814,622 shares, compared to its average volume of 948,986. Bioamber has a twelve month low of $0.32 and a twelve month high of $6.24. The company has a quick ratio of 0.75, a current ratio of 1.08 and a debt-to-equity ratio of 0.24.

BIOA has been the topic of a number of research reports. HC Wainwright reaffirmed a “buy” rating and set a $12.00 target price on shares of Bioamber in a research report on Wednesday, November 8th. Cowen reaffirmed a “hold” rating and set a $1.00 target price on shares of Bioamber in a research report on Friday, November 10th. Finally, ValuEngine lowered Bioamber from a “sell” rating to a “strong sell” rating in a research report on Friday, December 1st. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the stock. Bioamber presently has a consensus rating of “Hold” and an average target price of $6.50.

ILLEGAL ACTIVITY WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Affect Bioamber (BIOA) Share Price” was first published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at

About Bioamber

BioAmber Inc (BioAmber), formerly DNP Green Technology, Inc, is an industrial biotechnology company, which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products.

Insider Buying and Selling by Quarter for Bioamber (NYSE:BIOA)

Receive News & Ratings for Bioamber Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioamber and related companies with's FREE daily email newsletter.